Filed: 8/13/2026ACC: 0001420506-26-001563
📋 What this filing means
SILVERARC CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 73 equity positions with a total reported market value of $962.15M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
73
Positions
$962.15M
Total AUM (reported)
60.81M
Total Shares
Allocation by class
COM$615.21M63.9%
COM NEW$66.07M6.9%
ORD SHS$55.01M5.7%
CALL$37.91M3.9%
SPONSORED ADS$29.72M3.1%
COM SHS$29.70M3.1%
PUT$25.72M2.7%
Portfolio Concentration
Top 3$156.98M16.3%
4–10$250.20M26.0%
11–25$288.74M30.0%
Rest$266.24M27.7%
Top 3 weight
16.3%
Top 10 weight
42.3%
Voting Authority Distribution
Total shares with voting rights: 60.81M
Sole
Full voting authority
60.81M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole73
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings73
Rows:
ASCENDIS PHARMA A/S
SOLEShares206.23K
TypeSH
Market value$55.01M
5.72%
Sole
206.23K
Shared
0.00
None
0.00
CELCUITY INC
SOLEShares501K
TypeSH
Market value$52.41M
5.45%
Sole
501K
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares1.28M
TypeSH
Market value$49.56M
5.15%
Sole
1.28M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares1.30M
TypeSH
Market value$47.91M
4.98%
Sole
1.30M
Shared
0.00
None
0.00
IMMUNOME INC
SOLEShares2.02M
TypeSH
Market value$42.74M
4.44%
Sole
2.02M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares390K
TypeSH
Market value$38.02M
3.95%
Sole
390K
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares311.46K
TypeSH
Market value$34.58M
3.59%
Sole
311.46K
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares352.80K
TypeSH
Market value$33.58M
3.49%
Sole
352.80K
Shared
0.00
None
0.00
MONTE ROSA THERAPEUTICS INC
SOLEShares1.11M
TypeSH
Market value$26.82M
2.79%
Sole
1.11M
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares1.21M
TypeSH
Market value$26.55M
2.76%
Sole
1.21M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares489.38K
TypeSH
Market value$24.84M
2.58%
Sole
489.38K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares619.10K
TypeSH
Market value$23.85M
2.48%
Sole
619.10K
Shared
0.00
None
0.00
ERASCA INC
SOLEShares1.26M
TypeSH
Market value$23.14M
2.40%
Sole
1.26M
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
SOLEShares2.93M
TypeSH
Market value$22.63M
2.35%
Sole
2.93M
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares169.59K
TypeSH
Market value$22.60M
2.35%
Sole
169.59K
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
SOLEShares65.68K
TypeSH
Market value$21.99M
2.29%
Sole
65.68K
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares546.26K
TypeSH
Market value$21.28M
2.21%
Sole
546.26K
Shared
0.00
None
0.00
ARK ETF TR
SOLEShares500K
TypeSH
Market value$21.03M
2.19%
Sole
500K
Shared
0.00
None
0.00
DEFINIUM THERAPEUTICS INC
SOLEShares400K
TypeSH
Market value$18.82M
1.96%
Sole
400K
Shared
0.00
None
0.00
VERACYTE INC
SOLEShares318K
TypeSH
Market value$18.68M
1.94%
Sole
318K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares693.60K
TypeSH
Market value$15.16M
1.58%
Sole
693.60K
Shared
0.00
None
0.00
GUARDANT HEALTH INC
SOLEShares99.83K
TypeSH
Market value$14.98M
1.56%
Sole
99.83K
Shared
0.00
None
0.00
C4 THERAPEUTICS INC
SOLEShares3.03M
TypeSH
Market value$14.16M
1.47%
Sole
3.03M
Shared
0.00
None
0.00
ZENAS BIOPHARMA INC
SOLEShares509.79K
TypeSH
Market value$12.94M
1.34%
Sole
509.79K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares678.10K
TypeSH
Market value$12.65M
1.31%
Sole
678.10K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ASCENDIS PHARMA A/SSOLE | ORD SHS | 206.23K | SH | $55.01M 5.72% | 206.23K | 0.00 | 0.00 |
CELCUITY INCSOLE | COM | 501K | SH | $52.41M 5.45% | 501K | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 1.28M | SH | $49.56M 5.15% | 1.28M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 1.30M | SH | $47.91M 4.98% | 1.30M | 0.00 | 0.00 |
IMMUNOME INCSOLE | COM | 2.02M | SH | $42.74M 4.44% | 2.02M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 390K | SH | $38.02M 3.95% | 390K | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 311.46K | SH | $34.58M 3.59% | 311.46K | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 352.80K | SH | $33.58M 3.49% | 352.80K | 0.00 | 0.00 |
MONTE ROSA THERAPEUTICS INCSOLE | COM | 1.11M | SH | $26.82M 2.79% | 1.11M | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 1.21M | SH | $26.55M 2.76% | 1.21M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 489.38K | SH | $24.84M 2.58% | 489.38K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 619.10K | SH | $23.85M 2.48% | 619.10K | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 1.26M | SH | $23.14M 2.40% | 1.26M | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCSOLE | COM SER A | 2.93M | SH | $22.63M 2.35% | 2.93M | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 169.59K | SH | $22.60M 2.35% | 169.59K | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES ISOLE | COM NEW | 65.68K | SH | $21.99M 2.29% | 65.68K | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 546.26K | SH | $21.28M 2.21% | 546.26K | 0.00 | 0.00 |
ARK ETF TRSOLE | PUT | 500K | SH | $21.03M 2.19% | 500K | 0.00 | 0.00 |
DEFINIUM THERAPEUTICS INCSOLE | COM SHS | 400K | SH | $18.82M 1.96% | 400K | 0.00 | 0.00 |
VERACYTE INCSOLE | COM | 318K | SH | $18.68M 1.94% | 318K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | CALL | 693.60K | SH | $15.16M 1.58% | 693.60K | 0.00 | 0.00 |
GUARDANT HEALTH INCSOLE | COM | 99.83K | SH | $14.98M 1.56% | 99.83K | 0.00 | 0.00 |
C4 THERAPEUTICS INCSOLE | COM STK | 3.03M | SH | $14.16M 1.47% | 3.03M | 0.00 | 0.00 |
ZENAS BIOPHARMA INCSOLE | COM | 509.79K | SH | $12.94M 1.34% | 509.79K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 678.10K | SH | $12.65M 1.31% | 678.10K | 0.00 | 0.00 |
Page 1 of 3